These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 554811)

  • 1. [New derivatives of rifamycin SV. Esters, hydrazide amides of 3-carboxyrifamycin SV].
    Marchi E; Brufani M; Bellomo P
    G Ital Chemioter; 1979; 26(1-2):207-12. PubMed ID: 554811
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of isolated yeast and mycelial phase RNA polymerases of Histoplasma capsulatum by rifamycin derivatives.
    McMillian R; Medoff G; Schlessinger D; Kobayashi GS
    Sabouraudia; 1977 Nov; 15(3):257-61. PubMed ID: 601661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity of some ester, amides, and hydrazides of 3-carboxyrifamycin S. Relationship between structure and activity of ansamycins.
    Bellomo P; Marchi E; Mascellani G; Brufani M
    J Med Chem; 1981 Nov; 24(11):1310-4. PubMed ID: 7310806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative study of the effect of different rifamycins on bacterial cell metabolism and on the RNA-polymerase reaction in a cell-free system].
    Subbotina NA
    Antibiotiki; 1978 Mar; 23(3):239-42. PubMed ID: 345958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of rifamycins with mammalian nucleic acid polymerizing enzymes.
    Sethi VS; Okano P
    Biochim Biophys Acta; 1976 Dec; 454(2):230-47. PubMed ID: 63293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of T7 specific RNA polymerase. 3. Inhibition by derivatives of rifamycin SV.
    Chamberlin MJ; Ring J
    Biochem Biophys Res Commun; 1972 Nov; 49(4):1129-36. PubMed ID: 4641709
    [No Abstract]   [Full Text] [Related]  

  • 7. Biosynthetic and semisynthetic rifamycins.
    Sensi P
    Postepy Hig Med Dosw; 1972; 26(4):509-21. PubMed ID: 4635069
    [No Abstract]   [Full Text] [Related]  

  • 8. [RNA polymerase-rifamycin. A molecular model of inhibition].
    Chertov OIu; Obukhov AN; Lipkin VM
    Bioorg Khim; 1983 May; 9(5):633-40. PubMed ID: 6207842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of rifamycin derivatives on RNA polymerase of human leukemic lymphocytes.
    Tsai MJ; Saunders GF
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):2072-6. PubMed ID: 4516206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends in rifamycin research.
    Lal R; Lal S
    Bioessays; 1994 Mar; 16(3):211-6. PubMed ID: 7513153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition of Saccharomyces cerevisiae RNA polymerase by rifamycin derivatives (rifamycins and yeast RNA polymerase).
    Di Mauro E; Mezzina M; Arcà M
    Arch Biochem Biophys; 1974 Oct; 164(2):765-8. PubMed ID: 4618080
    [No Abstract]   [Full Text] [Related]  

  • 12. Structure-activity relationship studies of new rifamycins containing l-amino acid esters as inhibitors of bacterial RNA polymerases.
    Czerwonka D; Domagalska J; Pyta K; Kubicka MM; Pecyna P; Gajecka M; Przybylski P
    Eur J Med Chem; 2016 Jun; 116():216-221. PubMed ID: 27061985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives.
    Cellai L; Cerrini S; Segre AL; Battistoni C; Cossu G; Mattogno G; Brufani M; Marchi E; Venturini AP
    Farmaco; 1989 Feb; 44(2):97-107. PubMed ID: 2775416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxygen Enhancement of bactericidal activity of rifamycin SV on Escherichia coli and aerobic oxidation of rifamycin SV to rifamycin S catalyzed by manganous ions: the role of superoxide.
    Kono Y
    J Biochem; 1982 Jan; 91(1):381-95. PubMed ID: 6279585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of structure and activity in ansamycins: structure, conformation, and interactions of antibiotic rifamycin S.
    Arora SK
    J Med Chem; 1985 Aug; 28(8):1099-102. PubMed ID: 4020831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by derivatives of rifamycin of soluble ribonucleic acid polymerase from rat liver.
    Onishi T; Muramatsu M
    Biochem J; 1972 Aug; 128(5):1361-4. PubMed ID: 4643707
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypolipidemic activity of rifamycin derivatives.
    Traxler P; Kump W; Mueller K; Tosch W
    J Med Chem; 1990 Feb; 33(2):552-60. PubMed ID: 2299623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CGP 4832, a new semisynthetic rifamycin derivative highly active against some gram-negative bacteria.
    Wehrli W; Zimmermann W; Kump W; Tosch W; Vischer W; Zak O
    J Antibiot (Tokyo); 1987 Dec; 40(12):1733-9. PubMed ID: 2448280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of structure-activity relationships in 4-deoxypyrido[1',2'-1,2]imidazo[5,4-c]rifamycin SV derivatives by electron spectroscopy for chemical analysis and 1H NMR.
    Cellai L; Cerrini S; Segre A; Battistoni C; Cossu G; Mattogno G; Brufani M; Marchi E
    Mol Pharmacol; 1985 Jan; 27(1):103-8. PubMed ID: 3965922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrazones of 3-formylrifamycin SV. II - Hydrazide-hydrazones and semicarbazones: synthesis, antibacterial activity and other biological properties.
    Cricchio R; Cietto G; Rossi E; Arioli V
    Farmaco Sci; 1975 Sep; 30(9):695-703. PubMed ID: 1157918
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.